Inactivation of parvovirus B19 in coagulation factor concentrates by UVC radiation: Assessment by an in vitro infectivity assay using CFU-E derived from peripheral blood CD34+ cells

Transfusion

Volumn 41, Issue 4, 2001, Pages 456-461

  Sugawara, Hiroyuki ^a,b,c   Motokawa, Reiko ^a,b,c   Abe, Hideki ^a,b,c,d   Yamaguchi, Miki ^a,b,c   Yamada Ohnishi, Yoshiko ^a,b,c   Hirayama, Junichi ^a,b,c   Sakata, Hidekatsu ^a,b,c   Sato, Shinichiro ^a,b,c   Kamo, Naoki ^a,b,c   Ikebuchi, Kenji ^a,b,c   Ikeda, Hisami ^a,b,c  

^a Japanese Red Cross Society   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c TERUMO CORPORATION   (Japan)

^d NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; CATECHIN; CD34 ANTIGEN; EPIGALLOCATECHIN GALLATE;

ARTICLE; BLOOD COMPONENT THERAPY; COLONY FORMING UNIT E; CONTROLLED STUDY; DISEASE TRANSMISSION; HOST CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; INFECTION; METHODOLOGY; PARVOVIRUS; SAFETY; THERMOSTABILITY; ULTRAVIOLET C RADIATION; VALIDATION PROCESS; VIRUS DETECTION; VIRUS INACTIVATION; VIRUS LOAD;

ANTIGENS, CD34; BLOOD COAGULATION FACTORS; ERYTHROID PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; ULTRAVIOLET RAYS;

EID: 0035038524     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41040456.x     Document Type: Article

References (28)

1. Severely heated therapeutic factor VIII concentrate of high specific activity
2. Low risk of viral infection affer administration of vapor-heated factor VIII concentrate. International Investigator Group
3. Inactivation of the AIDS-causing retrovirus and other human viruses in antihemophilic plasma protein preparations by pasteurization
4. Inactivation of viruses in labile blood derivatives. I. Disruption of lipidenveloped viruses by tri(n-butyl) phosphate detergent combinations
5. Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates
6. Strategies for viral inactivation
7. The epidemiology of virus transmission by plasma derivatives: Clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1
8. Human parvovirus B19 infection in hemophiliacs first infused with two highpurity, virally attenuated factor VIII concentrates
9. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group
10. Parvovirus B19 infection in patients with hemophilia
11. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100°C heat after lyophilization
12. Hepatitis A virus infections associated with clotting factor concentrate in the United States
13. Virucidal treatment of blood protein products with UVC radiation
14. Virus inactivation of blood products by phenothiazine dyes and light
15. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation
16. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin
17. Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A and STAT5B in primary cultured human erythroid precursors
18. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chainbreaking antioxidants
19. Efficiency of donor screening for human parvovirus B19 by the receptor-mediated hemagglutination assay method
20. Human parvovirus B19 detected by receptor-mediated hemagglutination assay of pooled plasma for fractionation
21. A rapid nylon-fiber syringe system to deplete CD14+ cells for positive selection of human blood CD34+ cells. Use of immunomagnetic microspheres
22. A simple method of estimating 50 percent endpoints
23. Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity
24. Singlet oxygen involvement in ultraviolet (254 nm) radiation-induced formation of 8-hydroxy-deoxyguanosine in DNA
25. Cyclobutane pyrimidine dimers and (6-4) photoproducts block polymerization by DNA polymerase I
26. Misreading of DNA templates containing 8-hydroxy deoxyguanosine at the modified base and at adjacent residues
27. Virucidal short wavelength ultraviolet light treatment of plasma and factor VIII concentrate: Protection of proteins by antioxidants
28. Protecting fibrinogen with rutin during UVC irradiation for viral inactivation